C Du Manoir-Baumgarten

Suggest Changes
We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
4165 Background: Previous small phase II trials have demonstrated that IFN had clinical efficacy in DET. Predictive factors of response still remain unclear. METHODS Population: patients (pts) with(More)
6571 Background & Methods: This phase II study combined PEG-Intron to CHVP in place of interferon alfa-2b in untreated patients with follicular lymphoma and high-risk criteria (B symptoms, poor PS,(More)
  • 1